PAR-25-379 Native Health R01 Eligibility Guide
Updated 5 official sources
Quick Answer: PAR-25-379 eligibility in 2026 turns on 6 checks: Native health focus, community partnership, intervention logic, clinical-trial classification, R01 readiness, and participating-institute fit.
Full answer and how we checked it
Compare PAR-25-378 R34 when planning or feasibility work is still needed.
Who this is for: Tribal health researchers, Native-led research teams, Urban Indian health partners, Native Hawaiian health partners, intervention scientists, and sponsored-research offices deciding whether an NIH R01 is the right route.
Data note: This guide uses NIH PAR-25-379 (opens in a new tab), companion NIH PAR-25-378 R34 (opens in a new tab), NIH clinical trials policy (opens in a new tab), NOT-AR-25-017 (opens in a new tab), Grants.gov listing 358375 (opens in a new tab), all checked on October 10, 2026, with due dates rechecked October 24, 2026.
In this guide
- October 2026 Source Check
- 6 PAR-25-379 Eligibility Stop Checks
- 5 Funding, Timing, and Mechanism Rules
- 5 R01 Versus R34 Route Choices
- What NIH Doesn't Tell You
- 7 Evidence Assets That Make This R01 Stronger
- 21-Day Native Health R01 Routing Plan
- 6 Reviewer-Risk Signals to Fix
- 7 Source-Backed Signals From PAR-25-379
- 4 Signals To Check Before You Draft
- 5 Applicant Types and Best Next Move
- Sources
PAR-25-379 is not a generic health disparities R01. According to NIH PAR-25-379 (opens in a new tab), the NOFO supports research on interventions and related work to improve health in Native populations.
In NIH community-engaged applications, the central problem is often not weak science. It is weak partnership logic. For this route, the application has to show community fit, cultural relevance, intervention readiness, and institute fit without treating the community as a recruitment channel.
Use this guide with the live NIH Native Health Intervention R01 program record. Then compare NIH grants complete guide, NIH R01 R21 R03 K awards comparison, grants for substance abuse programs, what is a NOFO, and the Grantsights grant database.
October 2026 Source Check
As of October 24, 2026, PAR-25-379 is still the NIH R01 clinical-trial-optional route for Intervention Research to Improve Native American Health, but its last listed due date, October 21, 2026, has passed. NIH names no successor NOFO yet, says AIDS dates are not applicable after NIH removed AIDS dates from this NOFO, and lists January 8, 2027 as the expiration date. NIH also added NIAMS participation through NOT-AR-25-017, effective for the October 21, 2025 due date and subsequent due dates, so musculoskeletal, skin, and arthritis-related Native health projects should recheck institute fit before submission.
The March 31, 2025 source update matters for applicants because NIH tells teams to reread the full opportunity and adjust applications. The strongest public screen is now: prove Native community priority, governance, data rights, community review, intervention readiness, clinical-trial classification, R01 versus R34 fit, and participating-institute mission match before drafting aims.
| Current source owner | What the applicant should do |
|---|---|
| NIH PAR-25-379 | Watch for a reissue (its last due date, October 21, 2026, has passed), then confirm trial-optional status and participating institute list |
| NIH PAR-25-378 | Use the R34 when governance, feasibility, protocol, recruitment, or outcome-measure work is not ready for R01 scale |
| NIH notices | Check AIDS-date removal and NOT-AR-25-017 NIAMS participation before copying an old calendar |
| Grants.gov listing 358375 | Use as a federal record cross-check, not the only source |
Get grant deadline alerts by email
About once a week, we email a short list of open grant calls with real deadlines from different funders. It isn't limited to the programs in this guide.
No spam. Unsubscribe anytime.
6 PAR-25-379 Eligibility Stop Checks
6 stop checks decide whether the R01 fits. The project should center Native health, community partnership, intervention logic, clinical-trial classification, and participating-institute fit.
| Stop check | Strong R01 signal | Red flag |
|---|---|---|
| Population fit | Native community focus is explicit | Population is incidental |
| Community role | Community partners shape design and conduct | Partners only help recruit |
| Intervention logic | Development, testing, adaptation, or implementation path is clear | Broad needs assessment only |
| Mechanism scale | R01-ready design and team | Planning work belongs in R34 |
| Trial status | Clinical-trial status is explicit | Forms and protocol are unclear |
| Institute fit | Participating NIH institute mission match is clear | No institute fit |
Don't use this route as a label for any project with Native participants. The project should be built with community knowledge, resources, and priorities visible in the design.
5 Funding, Timing, and Mechanism Rules
5 public rules should appear before the specific aims page. According to NIH, PAR-25-379 is an R01 clinical trial optional NOFO. Its last due date was October 21, 2026, no due dates remain, and the NOFO expires January 8, 2027.
| Rule | Source-backed read |
|---|---|
| Funding number | PAR-25-379 |
| Mechanism | R01 research project grant |
| Clinical trial status | Optional |
| Companion planning route | PAR-25-378 R34 |
| Next due date | None remaining; the last one was October 21, 2026 |
| Expiration date | January 8, 2027 |
According to NIH, application budgets are not limited but must reflect project needs, and the total project period may not exceed 5 years.
5 R01 Versus R34 Route Choices
5 route choices matter before writing. The R01 is for a research project ready to proceed. The R34 is for planning, development, or feasibility work before a larger trial or project.
| Route | Better first read when... | Why |
|---|---|---|
| PAR-25-379 R01 | Intervention or related research is ready for full study | R01 scale fits |
| PAR-25-378 R34 | Trial or project needs planning and feasibility | Planning route fits |
| Parent R01 | Native health is relevant but IRINAH scope is not right | Broader route may fit |
| Institute-specific NOFO | Disease area has a better targeted path | Review fit may improve |
| Tribal or HRSA route | Program service delivery is the main need | NIH research route may not fit |
The honest answer is that the R34 may be the better first step when trust, governance, protocol, recruitment, or feasibility work still needs to be built.
What NIH Doesn't Tell You
4 hidden readiness questions decide whether this belongs under PAR-25-379. NIH gives the public rules, but it does not decide whether the partnership is real enough for review.
First, NIH does not make community engagement real because a letter exists. Governance, data rights, decision-making, compensation, and dissemination should be visible.
Second, NIH does not make all Native health research intervention research. Etiologic work can fit when it directly informs intervention development, but the path has to be stated.
Third, NIH does not remove clinical-trial complexity. If the study assigns an intervention to study health outcomes, the team should handle trial design, safety, data monitoring, and forms early.
Fourth, NIH does not guarantee institute fit. According to NIH, applications that do not align with a participating institute mission may be considered non-responsive.
One research team working with a Tribal health partner should be able to name the decision body, data-use terms, community review process, and return-of-results plan before writing aims. If those pieces are not real, skip the R01 for now and choose a better route, often PAR-25-378 R34 or a non-NIH service-funding path.
7 Evidence Assets That Make This R01 Stronger
7 evidence assets help a Native health R01 read as review-ready. The strongest application proves partnership, research fit, and next-step value.
First, define the Native population and community context. According to NIH, the NOFO includes American Indian, Alaska Native, Urban Indian, state-recognized Tribal, and Native Hawaiian communities as described in the announcement.
Second, show community governance. A tribal partner with a community advisory board, data-use agreement, cultural review process, and PI partnership has a stronger foundation than a university-only study.
Third, explain the intervention path. The project may develop, adapt, test, or study adoption of an intervention, but it should not read like a service program without research questions.
Fourth, connect cultural fit to design, not just language. Recruitment, measures, consent, intervention content, staffing, data return, and dissemination can all require community-specific decisions.
Fifth, handle sustainability and scale carefully. According to NIH, research may address adoption, integration, scale-up, and sustainability of effective interventions when evidence already supports that step.
Sixth, make clinical-trial status explicit. Clinical trial optional does not mean forms are optional.
Seventh, name the participating institute fit. The application should explain the disease area, institute mission, and program staff logic before submission.
21-Day Native Health R01 Routing Plan
21 days is enough to decide whether the team should draft. Days 1 through 3 should confirm source status, deadline, clinical-trial status, and participating institute fit.
Days 4 through 7 should test community readiness: governance, letters, data agreements, compensation, consent, dissemination, and community review.
Days 8 through 12 should compare R01 and R34. If protocol, recruitment, or intervention adaptation is still uncertain, the R34 may be cleaner.
Days 13 through 16 should write the intervention logic: problem, community knowledge, mechanism, outcomes, measures, trial status, and analysis.
Days 17 through 21 should run submission checks, including budget, human subjects, Tribal approvals if applicable, and program staff contact.
6 Reviewer-Risk Signals to Fix
6 risk signals should be fixed before submission. First, the application should not treat Native communities only as a study population.
Second, the intervention should not be culturally adapted in name only.
Third, the clinical-trial status should be explicit.
Fourth, institute fit should be named early.
Fifth, data governance should be clear, especially for community-level or Tribal data.
Sixth, the project should show how findings will return to the communities involved.
7 Source-Backed Signals From PAR-25-379
7 signals from NIH should shape this page and the applicant's routing memo. The first is that PAR-25-379 is an R01, so the research plan should be ready for full project review rather than only planning.
The second is clinical-trial optional status. A trial may fit, but the trial classification, human-subjects record, data monitoring plan, and protocol logic need to be settled early. They can't be patched at the end.
The third is community priority. NIH asks applicants to show that the research question is relevant to and prioritized by Native community partners. A letter alone won't prove that.
The fourth signal is cultural and community fit. The design should show how community knowledge, strengths, and local context affect measures, staffing, recruitment, intervention content, data rights, and dissemination.
The fifth signal is the R34 comparison. PAR-25-378 exists for teams that still need planning, feasibility, or protocol work. If governance or intervention design is still unsettled, the R34 may be cleaner.
The sixth signal is participating-institute fit. The disease area and mission match should be named before submission because non-responsive applications can lose before review.
The seventh signal is sustainability. NIH asks for work that can matter in the test communities and, when appropriate, support wider use. The application should be honest about what can scale and what should remain community-specific.
4 Signals To Check Before You Draft
4 signals help you decide whether to draft. Signal 1 is partnership readiness: community partners should shape design, conduct, data rights, and dissemination.
Signal 2 is route fit: compare PAR-25-379 R01 with PAR-25-378 R34 when governance, protocol, recruitment, or feasibility work is not settled.
Signal 3 is trial fit: clinical trial optional status still requires correct classification, forms, protocol logic, and monitoring.
Signal 4 is institute fit: the application needs a clear participating-institute match before submission.
5 Applicant Types and Best Next Move
5 applicant types commonly ask about PAR-25-379, and each should leave with a different next step.
| Applicant type | Best next move | Why |
|---|---|---|
| Native-led research team | Build R01 fit memo | Route may fit |
| University with community partner | Confirm governance and data rights | Partnership quality matters |
| Trial-planning team | Compare PAR-25-378 R34 | Planning route may fit |
| Service program | Compare HRSA or Tribal funding | NIH requires research aims |
| Sponsored-project office | Check trial status and institute fit | Technical issues can block |
The best answer is: use PAR-25-379 when the project is community-grounded, Native health centered, research-ready, correctly classified for trial status, and aligned with a participating NIH institute.
Sources
4 sources anchor this guide: the NIH R01 NOFO, the companion NIH R34 planning route, the federal listing, and the Grantsights public database record.
- NIH PAR-25-379 R01 NOFO: grants.nih.gov (opens in a new tab)
- NIH PAR-25-378 R34 planning route: grants.nih.gov (opens in a new tab)
- NIH NOT-AR-25-017 NIAMS participation notice: grants.nih.gov (opens in a new tab)
- Grants.gov listing 358375: grants.gov (opens in a new tab)
- Grantsights program record: NIH Native Health Intervention R01
Next steps
Where to go next
These next pages help you move from research into a specific grant choice.
Open the R01 record
Check PAR-25-379, October 2026 date, community priority, trial status, and source links.
Compare NIH mechanisms
Use when R01, R34, R21, or another NIH route may fit better.
Compare behavioral health
Use when the work may fit prevention, treatment, recovery, or service funding instead of NIH research.
Find grants that fit you
Free eligibility check: answer 9 questions and see ranked matches with deadlines and fit reasons.
Frequently Asked Questions
What does PAR-25-379 fund?
NIH says the R01 supports intervention and related research to improve health in Native populations.
Are clinical trials allowed?
Yes. PAR-25-379 is clinical trial optional.
What is the companion planning route?
NIH lists PAR-25-378 as the R34 clinical trial planning route.
What populations are included?
NIH defines Native Americans broadly for this NOFO, including American Indian, Alaska Native, Urban Indian, state-recognized Tribal, and Native Hawaiian communities as described in the NOFO.
Who should skip this route?
Skip it if the project lacks community partnership, cultural fit, intervention logic, or participating-institute fit.
Last updated October 24, 2026. Corrected October 24, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
PAR-25-317 family health R01 eligibility Guide
PAR 25 317 family health guide: 7 checks for eligibility, source status, budget, evidence, route fit, review criteria, and next steps in 2026.
RFA-ES-25-002 EHS Core Centers P30 eligibility Guide
EHS Core Centers P30 guide: 7 checks for eligibility, source status, budget, evidence, route fit, review criteria, and team readiness in 2026.
PAR-25-288 ED diversion R34 eligibility Guide
PAR 25 288 ED diversion guide: 7 checks for eligibility, source status, budget, evidence, route fit, review criteria, and team readiness in 2026.
Behavioral Health Workforce Grants 2026: BHWET Up to $600K
8+ federal programs fund behavioral health workforce training and loan repayment, including HRSA BHWET awards up to $600,000. Who qualifies and how.
Best Federal Grants for Community Health Centers 2026
Best federal grants for community health centers 2026: HRSA Section 330, 340B, Ryan White, SAMHSA. Real FY2024 data and award ranges for FQHCs.
Best Federal Grants for Mental Health Nonprofits 2026
12 FY2026 SAMHSA notices open to mental health nonprofits, who won FY2025 awards, plus foundation funders, state contracts, and Medicaid billing.